Form 4: OHI CIO Vikas Gupta Awarded Performance-Based Equity

Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, was awarded 81,929 Profits Interest Units based on 2023-2025 performance, vesting quarterly in 2026.

Summary

• Vikas Gupta, Chief Investment Officer of Omega Healthcare Investors Inc. (OHI), was awarded 81,929 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership.
• These PIUs were earned based on the company's Absolute Total Shareholder Return (59,449 units) and Relative Total Shareholder Return (22,480 units) for the 2023-2025 performance period.
• The Compensation Committee certified the performance as of January 8, 2026.
• The PIUs are earned but not yet vested; vesting will occur quarterly in 2026, with 25% vesting at the end of each quarter, subject to continued employment.
• Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") upon vesting and satisfaction of certain tax-driven economic requirements.
• Following these transactions, Vikas Gupta beneficially owns 114,166 derivative securities (PIUs).

Sentiment

Score: 7

Explanation: The filing reports a positive event of an executive receiving a significant performance-based equity award, indicating the company met its performance targets. This aligns management incentives with shareholder interests. No negative financial or operational news is present.

Positives

• The award of 81,929 Profits Interest Units to the Chief Investment Officer indicates that the company met strong performance metrics (Absolute and Relative Total Shareholder Return) for the 2023-2025 period.
• This equity award aligns management's interests with shareholder value creation, incentivizing long-term performance.

Risks

• Vesting of the Profits Interest Units is subject to continued employment, meaning the full benefit is contingent on the Chief Investment Officer remaining with the company through 2026.
• The PIUs are contingent rights and require the satisfaction of certain tax-driven economic requirements in addition to vesting before conversion to OP Units.

Future Outlook

The vesting schedule for the awarded Profits Interest Units extends through 2026, with 25% vesting at the end of each quarter, contingent on continued employment and certain tax-driven economic requirements.

Management Comments

• The Compensation Committee certified the performance for the 2023-2025 period as of January 8, 2026, leading to the award of Profits Interest Units.

Industry Context

Performance-based equity awards, such as Profits Interest Units tied to Total Shareholder Return, are a common practice in the REIT sector and broader public companies to incentivize executive performance and align management interests with long-term shareholder value.

Comparison to Industry Standards

• The use of Profits Interest Units (PIUs) tied to Absolute and Relative Total Shareholder Return (TSR) for executive compensation is a standard practice among publicly traded REITs and other companies.
• For example, Ventas, Inc. (VTR) and Welltower Inc. (WELL), other major healthcare REITs, also utilize performance-based equity awards, often including TSR metrics, to compensate their executives.
• The vesting schedule of 25% quarterly over a year post-performance period is also a common structure designed to retain talent and ensure sustained performance.

Stakeholder Impact

• Shareholders: Positive, as executive compensation is tied to performance metrics (TSR), aligning management's interests with shareholder value creation.
• Employees: No direct impact on general employees, but it signals a commitment to performance-based incentives for key personnel.

Next Steps

• Vesting of 25% of the awarded Profits Interest Units at the end of each quarter of 2026.
• Continued employment of Vikas Gupta through the vesting periods.
• Satisfaction of certain tax-driven economic requirements for conversion of PIUs to OP Units.

Key Dates

Recommendation

This Form 4 filing details a routine, performance-based equity award to a key executive, indicating the company met its compensation targets for the 2023-2025 period. While positive for management alignment, it does not present new material information that would fundamentally alter the investment thesis for Omega Healthcare Investors. Investors should continue to hold based on broader company fundamentals and market conditions, as this specific filing does not provide a strong catalyst for a 'buy' or 'sell' recommendation.

Keywords

Omega Healthcare Investors, OHI, Vikas Gupta, Profits Interest Units, PIUs, Equity Award, Executive Compensation, SEC Form 4, Insider Transaction, Total Shareholder Return, Performance-Based Compensation